Intra-Cellular Therapies (ITCI) Prices 10M Share Common Offering at $29.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
After-Hours Movers 01/06: (XERS) (CNXN) (MCHP) Higher; (ITCI) (ARE) (CRWD) Lower (more...)
January 6, 2020 5:55 PM ESTToday's After-Hours Movers
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS) 20.7% HIGHER; announced positive topline results from the in-clinic stage of a Phase 2 study of its developmental ready-to-use (RTU) glucagon for the prevention of hypoglycemia during and after moderate-to-high intensity aerobic exercise in adults with Type 1 diabetes mellitus (T1D).
PC Connection Inc. (NASDAQ: CNXN) 9% HIGHER; will replace Jagged Peak Energy in the S&P SmallCap 600.
Microchip Technology Incorporated, (NASDAQ:... More
Intra-Cellular Therapies (ITCI) Announces Proposed 10M Share Common Offering
January 6, 2020 4:07 PM ESTIntra-Cellular Therapies, Inc. (NASDAQ: ITCI) today announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock. In connection with the offering, Intra-Cellular Therapies intends to grant the underwriters a 30-day option to purchase up to an additional 15%... More
